UCI Mind
UCI MIND is a UC Irvine research institute conducting basic, translational, and clinical research on Alzheimer's disease and related dementias, serving research participants, clinicians, and community members across Southern California as one of 35 NIH-funded Alzheimer's Disease Research Centers.
- Company typePrivate
- Founded1984
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What UCI Mind does
UCI MIND is the Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine, and it has operated since 1984 as one of 35 NIH-designated Alzheimer's Disease Research Centers and the only federally-funded ADRC in Orange County. The institute's work spans basic, translational, and clinical research on Alzheimer's disease, frontotemporal dementia, Lewy body dementia, Huntington's disease, and related dementias, with specialized programs on populations at the extremes of risk (the 90+ oldest-old cohort and individuals with Down syndrome). Its technology base includes the first national induced pluripotent stem (iPS) cell bank for Alzheimer's disease, multi-modal PET imaging, biomarker and neuropathology cores, and emerging AI capabilities including speech-based digital biomarkers (LAMON, transformer models) and combined blood biomarker plus cognitive assessment predictive models.
UCI MIND's revenue model is characteristic of an academic medical research center: it does not sell commercial products or services to participants. Primary inflows come from federal grants — most notably a $21M NIA P30 ADRC renewal (July 2025) and an $18M LATE study grant (September 2025) — supplemented by philanthropic gifts (including an $80M campaign led by a $50M Quilter family donation in late 2025 for the new Ann Hutchinson Quilter Hall) and clinical trial revenues from pharmaceutical sponsors. Participants engage with the institute at no cost via clinical trials, observational studies, brain donation programs, and registries such as the Consent-to-Contact (C2C) Registry and the multi-institution CARE Registry targeting AANHPI populations.
The institute distributes its work through a community-led go-to-market model combining direct participant engagement, regional events (e.g., the 36th annual SoCal Alzheimer's Disease Research Conference), podcast and newsletter outreach, and an extended network of partnerships with advocacy organizations (Alzheimer's Orange County, Latino Health Access, Somang Society, Women's Alzheimer's Movement) and federal consortia (MODEL-AD, ABC-DS, Alzheimer's Prevention Initiative). Its primary segments are individuals with memory concerns and cognitively healthy older adults enrolling in research, with secondary segments including healthcare professionals and family caregivers.
UCI Mind firmographics
Firmographics- Name
- UCI Mind
- Legal name
- University of California Irvine Institute for Memory Impairments and Neurological Disorders
- Website
- https://mind.uci.edu
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- UCI MIND is a UC Irvine research institute conducting basic, translational, and clinical research on Alzheimer's disease and related dementias, serving research participants, clinicians, and community members across Southern California as one of 35 NIH-funded Alzheimer's Disease Research Centers.
- Ownership category
- akta.pro rank
UCI Mind industry classification
Industry- Product category
- Neuroscience Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)
- akta.pro secondary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where UCI Mind is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
UCI Mind business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- NIH and Federal Research Funding: Primary funding from National Institute on Aging grants including the ADRC P30 grant ($21 million renewal), $18 million LATE grant, and other NIH-funded research projects. UCI MIND has been continuously funded since 1984.
- Philanthropic Donations: Major gifts from donors including $80 million total (led by $50 million Quilter family gift) for construction of Ann Hutchinson Quilter Hall and general operations.
- Clinical Trial Revenue: Revenue from conducting clinical trials for pharmaceutical companies and research organizations studying Alzheimer's disease treatments.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
UCI Mind product offering
Product offeringCore offering
UCI MIND (Institute for Memory Impairments and Neurological Disorders) is an academic research institute at UC Irvine conducting translational research on Alzheimer's disease and related dementias, including frontotemporal, Lewy body, and Huntington's disease. It operates one of 35 NIH-funded Alzheimer's Disease Research Centers (ADRCs), runs clinical trials, maintains research registries (C2C and CARE), houses the first national iPS cell bank for Alzheimer's, and delivers training programs, community education, and professional diagnostic resources. Revenue comes primarily from NIH grants, philanthropic donations, and sponsored clinical trial contracts.
Product overview
UCI MIND is a research institute (not a commercial product company) operating as one of 35 NIH-funded Alzheimer's Disease Research Centers. The organization's primary offerings are research programs and services rather than commercial products. Core programs include the ADRC with multiple specialized cores (Clinical, Neuropathology, iPS Cell, Biomarker, Outreach/Recruitment, Down Syndrome, Oldest Old), training grants (T-32, T-35), and research registries (C2C, CARE). Notable products include LAMON (speech-based digital biomarker technology for early dementia detection) and the iPS Cell Core (first national stem cell bank for Alzheimer's). Services include clinical trials, educational programs (MINDcast podcast, MIND Matters newsletter), professional diagnostic toolkits, community conferences (SoCal AD Research Conference), and specialized research on Down syndrome and oldest-old populations.
Differentiator
Problem solved
Functional benefit
Brands
- UCI MIND: Common abbreviation for University of California Irvine Institute for Memory Impairments and Neurological Disorders
- Consent-to-Contact Registry
- Anteaters Against Alzheimer's
- Ann Hutchinson Quilter Hall
Products and services
- Alzheimer's Disease Research Center (ADRC) One of 35 NIH-funded Alzheimer's Disease Research Centers in the U.S. and the only center in Orange County, providing comprehensive research infrastructure across Clinical, Neuropathology, Data Management and Statistics, Biomarker, Outreach/Recruitment, Down Syndrome, and Oldest Old cores for translational dementia research.
- Induced Pluripotent Stem Cell (iPS) Core The first national iPS cell bank dedicated to Alzheimer's disease, providing researchers with patient-derived stem cells to study disease mechanisms and develop therapeutics.
- Clinical Trials Program Comprehensive clinical trial opportunities for individuals with and without memory concerns, testing new treatments and interventions for Alzheimer's disease and related dementias, including industry-sponsored and investigator-initiated studies.
- C2C Registry (Consent-to-Contact Registry) Research participation registry connecting individuals with memory concerns and healthy volunteers to appropriate research studies and clinical trials across the institute's research portfolio.
- CARE Registry Collaborative Approach for AANHPI Research and Education Registry focused on increasing representation of Asian American, Native Hawaiian, and Pacific Islander populations in aging and dementia research, partnered with UCSF.
- NIH-Funded Training Programs (TITAN T-32, Neurobiology of Aging T-32, RAMP/SMAART T-35) NIH-funded training grants (TITAN T-32, Neurobiology of Aging T-32, RAMP/SMAART T-35) that train the next generation of scientists and clinicians in brain aging and dementia research, plus the Anteaters Against Alzheimer's student engagement program.
- LAMON Early Dementia Detection Technology Early dementia detection technology using speech-based digital biomarkers and transformer models to identify cognitive impairment through voice pattern analysis. Developed in Dr. Sajjadi's lab.
- Center for Aging Research in Down Syndrome (CFAR-DS) Research center dedicated to understanding and addressing Alzheimer's disease in individuals with Down syndrome, who have elevated lifetime risk of developing dementia due to trisomy of chromosome 21.
- Diagnostic Toolkit and Clinical Care Guidelines (ACCT-AD) Professional resources including the Assessment of Cognitive Complaints Toolkit (ACCT-AD), diagnostic manuals, and clinical care guidelines for healthcare providers evaluating patients with cognitive complaints.
- SoCal Alzheimer's Disease Research Conference Annual regional conference bringing together researchers, clinicians, and community members to share advances in Alzheimer's disease research; the 36th edition was held in 2026.
Quantifiable outcome
- First to establish dedicated cores for iPS cells and special populations research
- +1 more outcomes
Companies that use UCI Mind
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
UCI Mind technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature3 records
UCI Mind partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Latino Health AccesscorePartnership with Latino Health Access (LHA) for community outreach and health equity initiatives. Dr. America Bracho leads LHA, which has empowered Latino families in Orange County for over three decades in health and wellness programs.
- Programs in Medical Education (PRIME) LEAD-ABCminorPartnership with UCI School of Medicine's PRIME Leadership Education to Advance Doctoring - African, Black and Caribbean (LEAD-ABC) program for brain health conversations with Black communities in Southern California.
- UCI Claire Trevor School of the ArtsminorCollaboration with UCI music department on Finding Light: Alzheimer's Stories choral concert and other arts-based community engagement events.
- CARE Registry (Collaborative Approach for AANHPI Research and Education)coreLeadership partnership with UCSF on the CARE Registry addressing underrepresentation of Asian American, Native Hawaiian, and Pacific Islander populations in aging and dementia research. UCI MIND's Dr. Joshua Grill serves as co-investigator.
- Alzheimer's Orange CountycoreCommunity partnership for annual Southern California Alzheimer's Disease Research Conference and mutual support for Orange County families affected by dementia.
- Somang SocietyminorPartnership supporting Korean American communities in Southern California with dementia resources and UCI MIND research outreach.
- Women's Alzheimer's Movement (WAM) at Cleveland CliniccorePartnership since 2018 supporting UCI MIND WAM Women's Initiative to understand sex disparity in Alzheimer's disease, funding researchers like Drs. María Corrada and Karen Lincoln.
- Model Organism Development and Evaluation for Late-onset Alzheimer's Disease (MODEL-AD) ConsortiumcoreUCI MIND contributes to this NIH-funded consortium developing and characterizing mouse models for late-onset Alzheimer's disease research.
- Alzheimer's Biomarker Consortium - Down Syndrome (ABC-DS)coreMulti-site NIH-funded study on Alzheimer's disease biomarkers in individuals with Down syndrome, with UCI MIND investigators leading key components.
- Banner Alzheimer's Institute (Alzheimer's Prevention Initiative)coreCollaboration on Alzheimer's prevention research, with UCI MIND Director Joshua Grill participating in prevention initiative meetings.
Scale indicators9 records
Recent moves8 records
Expansion highlights5 records
UCI Mind competitors and assessment
Company assessmentDirect peers
- Banner Alzheimer's Institute: One of the most prominent NIH-aligned ADRCs and a leader in Alzheimer's prevention research. Directly comparable to UCI MIND as an ADRC running prevention trials, biomarker programs, and the Alzheimer's Prevention Initiative (a stated UCI MIND partner).
- UCSF Memory and Aging Center: UCSF's dementia research center, which co-leads the CARE Registry with UCI MIND. Comparable as a peer ADRC with overlapping population research, clinical trial activity, and biomarker/translational work.
- Mayo Clinic Alzheimer's Disease Research Center: Major NIH-funded ADRC with deep clinical and research programs in Alzheimer's and related dementias. Comparable to UCI MIND as a peer ADRC competing for trials, talent, and consortia participation.
- Washington University Knight ADRC: One of the most cited ADRCs, with leadership in dominantly inherited Alzheimer's research (DIAN). Comparable to UCI MIND as a peer ADRC and a powerhouse in autosomal-dominant and biomarker studies.
- University of Washington Alzheimer's Disease Research Center: One of the original NIH-designated ADRCs with a long-running research program in dementia and aging. Directly comparable to UCI MIND as a fellow ADRC with multiple cores, longitudinal cohort studies, and clinical trial infrastructure.
- Massachusetts General Hospital ADRC (Harvard): Harvard-affiliated ADRC with one of the largest dementia research programs in the U.S. Directly comparable as a peer ADRC running clinical trials, biomarker research, and translational neuroscience on Alzheimer's disease.
- Stanford Alzheimer's Disease Research Center: Northern California-based NIH ADRC with strong neuroimaging and biomarker capabilities. Comparable to UCI MIND as a peer ADRC in California competing for federal grants, trials, and faculty.
Broad incumbents
- Cleveland Clinic Lou Ruvo Center for Brain Health: Wider-portfolio brain health center with Alzheimer's clinical care, research, and the Women's Alzheimer's Movement (WAM) — a UCI MIND partner. Comparable as a peer dementia research site with clinical and translational capability.
- Alzheimer's Association: National nonprofit driving Alzheimer's research funding, advocacy, and conferences (e.g., AAIC). Comparable to UCI MIND as a major funder/convener in the Alzheimer's research ecosystem that intersects with and supports ADRC activity.
Emerging players
- Allen Institute for Brain Science: Nonprofit research organization generating large-scale neuroscience datasets and tools, including in Alzheimer's. Comparable to UCI MIND as a fellow nonprofit research organization pushing open-science resources in dementia and brain aging.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
UCI Mind social profiles
Digital presenceUCI Mind financial estimates
Financial estimateRevenue estimate
Valuation estimate
UCI Mind leadership team
Management profileNumber of profiles
Profiles11 records
UCI Mind funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UCI Mind M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UCI Mind
What does UCI Mind do?
UCI MIND (Institute for Memory Impairments and Neurological Disorders) is an academic research institute at UC Irvine conducting translational research on Alzheimer's disease and related dementias, including frontotemporal, Lewy body, and Huntington's disease. It operates one of 35 NIH-funded Alzheimer's Disease Research Centers (ADRCs), runs clinical trials, maintains research registries (C2C and CARE), houses the first national iPS cell bank for Alzheimer's, and delivers training programs, community education, and professional diagnostic resources. Revenue comes primarily from NIH grants, philanthropic donations, and sponsored clinical trial contracts.
Is UCI Mind a public or private company?
UCI Mind is a private company. It is classified as state government owned and is currently operating.
When was UCI Mind founded?
UCI Mind was founded in 1984. It employs 1 to 10 people.
Where is UCI Mind based?
UCI Mind is headquartered in Irvine, United States, in the North America region.
How does UCI Mind make money?
Three revenue lines are on record. NIH and Federal Research Funding is the primary driver. The others are philanthropic Donations and clinical Trial Revenue.
Who are UCI Mind's main competitors?
Direct peers on record are Banner Alzheimer's Institute, UCSF Memory and Aging Center, Mayo Clinic Alzheimer's Disease Research Center, Washington University Knight ADRC, University of Washington Alzheimer's Disease Research Center, Massachusetts General Hospital ADRC (Harvard) and Stanford Alzheimer's Disease Research Center. Broad incumbents are Cleveland Clinic Lou Ruvo Center for Brain Health and Alzheimer's Association. Allen Institute for Brain Science is listed as an emerging player.
Does UCI Mind have an API?
No public API is recorded for UCI Mind.
What industry is UCI Mind in?
UCI Mind's product category is Neuroscience Research. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs), with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 5417 and its SIC code is 8731.